Latest News for PTCHF
BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial...
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial public offering at the top of its target range, putting the clinical-stage neuropsychiatry company on course to raise gross proceeds of $254.9 million. In London, PureTech shareholders saw the share price climb 9.56% to 139.8p.
PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PTCHF.
Senate Trading
No Senate trades found for PTCHF.
U.S. House Trading
No House trades found for PTCHF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.